Quantcast

Posts related to ‘MEDX’

The 52-Week Low Club (SGP)(PAY)(DEEP)

Posted: April 2, 2008 at 2:45 pm

Superior Offshore (DEEP) Company warns of liquidity problems. Down to $1.20 from 52-week high of $19.58.Medarex (MEDX) Pfizer ends joint drug trial. Sells off to $7.44 from 52-week high of ...
Read Full Story »

Medarex Tanks On Pfizer Study Halt (PFE, MEDX)

Posted: April 2, 2008 at 8:15 am

Medarex Inc. (NASDAQ: MEDX) Saw shares plummet in pre-market trading.  Pfizer Inc. (NYSE: PFE) has ended a Phase III clinical trial of tremelimumab in patients with advanced melanoma after a ...
Read Full Story »

Melanoma Patients Have Another Hope With New Orphan Drug Designation (ADH, MEDX)

Posted: February 22, 2008 at 8:52 am

Adherex Technologies Inc. (AMEX: ADH) has announced that it has received an orphan drug designation for its ADH-1 from the FDA for the use of ADH-1 in conjunction with melphalan ...
Read Full Story »

Top 10 Pre-Market Analyst Calls (ADBL, GOOG, LOW, MXIM, MEDX, MS, MOT, OI, TIVO, DIS)

Posted: February 1, 2008 at 7:43 am

Below are ten of the top analysts calls that247WallSt.com is looking at this morning:Audible (NASDAQ: ADBL) downgraded to Hold from Buy at Citigroup.Google (NASDAQ: GOOG) downgraded to Hold from Buy ...
Read Full Story »

Top 10 Pre-Market Analyst Calls (ADCT, ARRS, EL, FLML, GERN, HD, LOW, MCD, MEDX, NOVL, NMX, DIS)

Posted: January 29, 2008 at 7:54 am

These are not the only pre-market analyst calls that are moving stocks, but these are the calls that 247WallSt.com is focusing on:ADC Telecom (NASDAQ: ADCT) and Arris (NASDAQ: ARRS) raised ...
Read Full Story »

Top 10 Pre-Market Analyst Calls (CAT, EMN, GIS, K, GNTX, MEDX, MRK, N, NE, PLT, WAG)

Posted: January 28, 2008 at 7:22 am

These are not the only analyst calls impacting stocks pre-market, but these are the top calls that 247WallSt.com is focusing on:Caterpillar (NYSE: CAT) raised to Outperform at Bear Stearns.Eastman Chemical ...
Read Full Story »

Medarex Gets A Small Handout From Amgen (MEDX, AMGN)

Posted: December 18, 2007 at 9:06 am

Medarex, Inc. (NASDAQ: MEDX) has announced that it will receive a milestone payment from Amgen (NASDAQ: AMGN).  Unfortunately, Medarex said the amount is for an undisclosed sum for advancing an ...
Read Full Story »

Biotech Short Interest NOV 2007 II (AMGN, BIIB, CELG, GENZ, GILD, IMCL, MEDX)

Posted: December 11, 2007 at 5:30 pm

We've had a lot of biotech stocks see their shares get the wrath of news over recent days.  Now that the November-end NASDAQ Short Interest has been released, we wanted ...
Read Full Story »

The 52-Week Low Club

Posted: December 11, 2007 at 4:38 pm

AMR (AMR) High fuel prices and predictions industry will lose money in Q4. Drops to $17.60 from 52-week high of $41.NCI Building Systems (NCS) Company says it will miss 2008 ...
Read Full Story »

Pre-Market Stock News (December 11, 2007)

Posted: December 11, 2007 at 8:17 am

Below is a snapshot of the individual company news affecting share prices being watched by 247WallSt.com:Amtech Systems (NASDAQ: ASYS) shares up 3% after it announced receipt of a $3.9 million ...
Read Full Story »

Top 10 Pre-Market Analyst Calls (APD, PX, AMX, GOL, MA, MMM, UTX, MEDX, NEM, UBS, VIP, WWY)

Posted: December 11, 2007 at 7:43 am

These are not at all the only analyst calls being covered or making an impact in stocks this morning, but these are the ones 247WallSt.com is focusing on initially this ...
Read Full Story »

Medarex Stubs Its Toe (MEDX, BMY, DNDN)

Posted: December 10, 2007 at 4:57 pm

Medarex inc. (NASDAQ: MEDX) is seeing shares slapped in after-hours trading after the company is issuing disappointing news over the hopes for its Ipilimumab Pivotal Trials in patients with Advanced ...
Read Full Story »

Deciphering Medarex Earnings (MEDX)

Posted: October 31, 2007 at 3:50 pm

Some traders might bother peering at the losses on Medarex (NASDAQ:MEDX), but all we are looking at for the time being is the forward study data and the company's use ...
Read Full Story »

Medarex Hit With Sell Rating (MEDX, BMY)

Posted: October 17, 2007 at 7:51 am

Medarex (NASDAQ:MEDX) is seeing shares being hit by a research note where Banc of America initiated coverage with a "SELL" rating.  This is a fairly thin volume stock in pre-market ...
Read Full Story »

Evaluating Medarex & Bristol-Myers Huge Options Open Interest (MEDX, BMY, DNDN)

Posted: October 12, 2007 at 1:05 pm

We were screening options activity today and something came up that where bets had significantly grown from our prior coverage.  Earlier this year we covered some strange biotech options activity ...
Read Full Story »